GE Ventures was founded in 2013 and has since invested in more than 100 companies. Among these are Evidation Health, a digital medicine company GE launched with Stanford Health Care; Vitruvian Networks, a platform to advance cell and gene therapies built in collaboration with Mayo Clinic; and Vineti, an analytics platform for genomics research.
The company is reportedly hoping to sell its portfolio as a package deal, rather than as individual investments.
“During this time of transformation for GE, we are evaluating strategic options for GE Ventures to continue delivering returns for our shareholders and partners,” Megan Newhouse, a GE spokesperson, told CNBC in a statement. “While we can’t comment specifically on that process, we remain committed to supporting our portfolio companies, business units and partnering with the entrepreneurial ecosystem.”
More articles about health IT:
Multiple Myeloma Research Foundation launches CureCloud data hub for precision medicine
How Adventist Health White Memorial used an app to improve OR turnaround time by 10%
9 recent vendor contracts, go-lives
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
